ARCHIVES

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990

NCI, NSABP Launch Taxifin Trial For Prevention Of Breast Cancer

May 8, 1992

Funding opportunities listed.

June 25, 2004

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

June 16, 1999

Guest Editorial: Anil Potti Hires “Online Reputation Managers” As Journals Retract His Biomarker Research

April 15, 2011

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993